Subscreva a nossa newsletter para se manter atualizado
Clique aqui
  • BLS

Safety guide: Asbestos

BLS Safety Guide: Asbestos


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.

The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.

The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).

The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.

The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.

The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.

From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).

 

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Artigos relacionados

fevereiro 24, 2023 Product focus | New BLS Zer0

I facciali filtranti BLS Zer0 cambiano volto La massima protezione incontra la sostenibilità   La protezione di un FFP3 con la resistenza respiratoria di un FFP1. I facciali filtranti a coppa della serie BLS Zer0, con protezione FFP3, rappresentano uno dei principali prodotti della gamma BLS. Con o senza valvola di espirazione Eolo, con o […]

Link
março 15, 2022 Filtering facepieces protection

Sapresti dire quali sono le differenze tra una mascherina FFP2 e una FFP3? I facciali filtranti, o Filtering Face Pieces (FFP) proteggono dai cosiddetti "particolati", i quali identificano comunemente diversi tipi di particelle presenti nell'aria: le polveri, le nebbie e i fumi. In questa tipologia di prodotti il livello di protezione viene definito in base […]

Link
setembro 29, 2022 Yamaha VR46 | The Master Camp

Conosci il progetto Yamaha VR46 Master Camp? Tavullia, Italia Oggi alla sua 10^ edizione, The Master Camp è una iniziativa nata nel 2016 da Yamaha e VR46 Academy per far crescere nuovi talenti nel motociclismo. VR46 Racing Team è la squadra di motomondiale nata da Valentino Rossi per far emergere e valorizzare le giovani promesse […]

Link

Assine a newsletter

Receba atualizações sobre nossos eventos, notícias, catálogo e iniciativas futuras.
Inscreva-se

Contate-nos

Escreva-nos, responderemos em 48 horas.
Pedir informação

BLS S.R.L.
Società a Socio Unico
via dei Giovi, 41 - 20032 Cormano (MI) - Italia
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacy Policy - Cookie Policy

Sede legal
via dei Giovi, 41 – 20032 Cormano (MI) - Italia
Capitale Sociale | Share Capital: Euro 600.000,00 i.v.
C.C.I.A.A. - R.E.A.: MI 1186898
Partita IVA | VAT N°: IT12296780153
C.F. e Iscrizione al Registro delle Imprese di Milano: 07822320151

BLS IBERIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spain
BLS NORTHWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - The Netherlands
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazil
BLS GERMANY / Steindeich 1a, 25377 Kollmar - Germany
BLS FRANCE / 18 Porte du Grand Lyon 01700 Neyron - France

crossmenuchevron-downcross-circle
PT